Track: Advances and Latest trends on diabetic research
Researchers have discovered a completely unique and druggable insulin inhibitory receptor, named inceptor. The blocking of inceptor function results in an increased sensitisation of the insulin signaling pathway. Recent approaches in drug discovery have contributed to the event of latest class of therapeutics like Incretin mimetics, Amylin analogues, GIP analogs, Peroxisome proliferator activated receptors, and dipeptidyl peptidase-4 inhibitor as targets for potential drugs in diabetes treatment.
• Drug research on Diabetes
• Drug/Chemical induced diabetes
• Artificial Pancreas
Scientific Highlights
- Diabetes Mellitus and Research
- Endocrine Gland and Disorders
- Types of Diabetes
- Diabetes Symptoms and Complications
- Nursing care and Management on Diabetes
- Endocrine and Hormonal imbalance
- Diabetic clinical care and Prevention
- Obesity and Metabolism for Diabetes
- Reproductive Endocrinology & Infertility
- Pediatric Endocrinology
- Pituitary and Neuroendocrinology
- Diabetic Retinopathy
- Treatment and Therapies for Diabetes
- Pancreatitis and Role of insulin
- Cardiovascular risk on diabetes
- Clinical Endocrinology
- Advances and Latest trends on diabetic research
- COVID19 and Diabetes
- Genetics of Diabetes
- Thyroid
- Diabetic Nephropathy
- Business and Medical devices research on Diabetes
- Endocrine Surgery
- Diabetic foot
- Stem Cell treatment in Diabetes
- Steroid Hormones and Receptors
Organization Location
#1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Drop us an email for Program enquiry
diabetes@scientexevents.com
General Queries
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
diabetes@scientexconferences.com
Our Social Presence
Call us at
USA :(+1) 307 464 7366